Bangkok Dusit Medical Services Public Company Limited (BDMS)

Name: Bangkok Dusit Medical Services Public Company Limited (BDMS) — storico dei bilanci
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-09-19

Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. It operates through two segments Hospital Operations; and Other Businesses That Support Hospital Business. The company operates hospitals under the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital, and Royal Hospital Group names; and BDMS Wellness Clinic.

Dati chiave

Capitalizzazione di mercato: THB 316 billion
Ricavi (esercizio chiuso a 2025-12-31): THB 111.5B
Utile netto: THB 15.8B
Margine lordo: 36.1%
Margine netto: 14.2%

Vedi grafici interattivi e bilanci completi →

Conto economico annuale

Conto economico	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Entrate totali	THB 111.5B	THB 107.9B	THB 100.9B	THB 91.9B	—
Utile lordo	THB 40.2B	THB 39.8B	THB 37.4B	THB 33.6B	—
Risultato Operativo (EBIT)	THB 20.2B	THB 20.5B	THB 18.9B	THB 17.0B	—
Reddito netto	THB 15.8B	THB 16.0B	THB 14.4B	THB 12.6B	—

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di BDMS. /companies/us/BDMS

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.